
CHMP Recommends EU Approval of Zanidatamab for HER2+ Advanced Biliary Tract Cancer
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the conditional approval of zanidatamab (Ziihera) for the treatment of adult patients with unresectable locally …